<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04783363</url>
  </required_header>
  <id_info>
    <org_study_id>2020-012</org_study_id>
    <nct_id>NCT04783363</nct_id>
  </id_info>
  <brief_title>Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care</brief_title>
  <acronym>SNOEZELEN</acronym>
  <official_title>Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de cancérologie Strasbourg Europe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de cancérologie Strasbourg Europe</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a monocentric, comparative, open-label, randomized, crossover study enrolling&#xD;
      patients hospitalized in Strasbourg Europe Cancerology Institute, receiving repeated invasive&#xD;
      care for cancer treatment.&#xD;
&#xD;
      The purpose of this study is to compare the satisfaction of patients, regarding their&#xD;
      perception of care, with or without Snoezelen session.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will followed during two visits for a repeated invasive care. They will be&#xD;
      randomized to two groups in a 1:1 ratio.&#xD;
&#xD;
      Crossover plan and arms are described as follow:&#xD;
&#xD;
      Arm A : Visit 1 with Snoezelen session before invasive care and Visit 2 without Snoezelen&#xD;
      session before invasive care (standard care)&#xD;
&#xD;
      Arm B : Visit 1 without Snoezelen session before invasive care (standard care) and Visit 2&#xD;
      with Snoezelen session before invasive care&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 1</measure>
    <time_frame>immediately after invasive care at Visit 1</time_frame>
    <description>Evaluation using a modified Visual Analog Scales, Oberts, 1984</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 2</measure>
    <time_frame>immediately after invasive care at Visit 2</time_frame>
    <description>Evaluation using a modified Visual Analog Scales, Oberts, 1984</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in patient perceived pain, with or without Snoezelen session</measure>
    <time_frame>At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2</time_frame>
    <description>Numeric visual analog scale (0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in patient perceived anxiety, with or without Snoezelen session</measure>
    <time_frame>At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2</time_frame>
    <description>Numeric visual analog scale (0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparing relationship between patient and caregiver, with or without Snoezelen session</measure>
    <time_frame>immediately after invasive care at Visit 1 ; immediately after invasive care at Visit 2</time_frame>
    <description>Numeric visual analog scale (0 to 10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Arm A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Visit 1: with Snoezelen session before invasive care&#xD;
Visit 2: standard care (=without Snoezelen session) before invasive care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Visit 1: standard care (=without Snoezelen session) before invasive care&#xD;
Visit 2: with Snoezelen session before invasive care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Snoezelen session</intervention_name>
    <description>before one of two repeated invasive care</description>
    <arm_group_label>Arm A</arm_group_label>
    <arm_group_label>Arm B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients treated for cancer and hospitalized for invasive care&#xD;
&#xD;
          -  Two programmed hospitalization for repeated care&#xD;
&#xD;
          -  Patients receiving one of the following invasive care: Huber needle application&#xD;
             (transfusion, parenteral nutrition), complex wound dressing, intrathecal chemotherapy,&#xD;
             ascites fluid or pleural puncture&#xD;
&#xD;
          -  Patients must be ≥ 18 years old&#xD;
&#xD;
          -  Performance Status ≤ 3&#xD;
&#xD;
          -  Absence of psychiatric disorder impairing follow-up&#xD;
&#xD;
          -  Ability to speak, understand, write and read French&#xD;
&#xD;
          -  Signed informed consent from the patient&#xD;
&#xD;
          -  Affiliation to social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients presenting infectious symptoms requiring isolation&#xD;
&#xD;
          -  Patients &lt; 18 years old or patients ≥ 18 years old under supervision&#xD;
&#xD;
          -  Patients placed under judicial protection or guardianship&#xD;
&#xD;
          -  Women that are pregnant or breast-feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valérie SARTORI</last_name>
    <phone>368767223</phone>
    <phone_ext>33</phone_ext>
    <email>v.sartori@icans.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manon VOEGELIN, PhD</last_name>
    <phone>368767360</phone>
    <phone_ext>33</phone_ext>
    <email>promotion-rc@icans.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de cancérologie Strasbourg Europe</name>
      <address>
        <city>Strasbourg</city>
        <zip>67033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie SARTORI</last_name>
      <phone>368767223</phone>
      <phone_ext>33</phone_ext>
      <email>v.sartori@icans.eu</email>
    </contact>
    <contact_backup>
      <last_name>Manon VOEGELIN</last_name>
      <phone>368767360</phone>
      <phone_ext>33</phone_ext>
      <email>m.voegelin@icans.eu</email>
    </contact_backup>
    <investigator>
      <last_name>Francine THIRIET-PFEIL, Health Manager</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elodie RIEB, Care Assistant</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Supportive care</keyword>
  <keyword>Snoezelen</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

